Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression

Por Wang, Lei, Devarajan, Eswaran, He, Jin, Reddy, Sekhar P., Le Dai, Jia
Publicado em 2005

Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis

Por Egas-Bejar, Daniela, Anderson, Pete M., Agarwal, Rishi, Corrales-Medina, Fernando, Devarajan, Eswaran, Huh, Winston W., Brown, Robert E, Subbiah, Vivek
Publicado em 2014

Adipose Tissue-Derived Stem Cells Differentiate into Carcinoma-Associated Fibroblast-Like Cells under the Influence of Tumor-Derived Factors

Por Jotzu, Constantin, Alt, Eckhard, Welte, Gabriel, Li, Jie, Hennessy, Bryan T., Devarajan, Eswaran, Krishnappa, Srinivasalu, Pinilla, Severin, Droll, Lilly, Song, Yao-Hua
Publicado no Anal Cell Pathol (Amst) (2010)

BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation

Por Lewis, Valerae O., Devarajan, Eswaran, Cardó-Vila, Marina, Thomas, Dafydd G., Kleinerman, Eugenie S., Marchiò, Serena, Sidman, Richard L., Pasqualini, Renata, Arap, Wadih
Publicado no Proc Natl Acad Sci U S A (2017)

Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine

Por Subbiah, Vivek, Wagner, Michael J., McGuire, Mary F., Sarwari, Nawid M., Devarajan, Eswaran, Lewis, Valerae O., Westin, Shanon, Kato, Shumei, Brown, Robert E., Anderson, Pete
Publicado no Oncotarget (2015)